000 01278 a2200349 4500
005 20250517035206.0
264 0 _c20160509
008 201605s 0 0 eng d
022 _a1998-3751
024 7 _a10.4103/0253-7613.157134
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSawant, Neena S
245 0 0 _aNeuroleptic malignant syndrome in cycloserine-induced psychosis.
_h[electronic resource]
260 _bIndian journal of pharmacology
_c
300 _a328-9 p.
_bdigital
500 _aPublication Type: Case Reports; Journal Article
650 0 4 _aAdult
650 0 4 _aAntibiotics, Antitubercular
_xadverse effects
650 0 4 _aAntiparkinson Agents
_xtherapeutic use
650 0 4 _aAntipsychotic Agents
_xadverse effects
650 0 4 _aBromocriptine
_xtherapeutic use
650 0 4 _aCycloserine
_xadverse effects
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aNeuroleptic Malignant Syndrome
_xcomplications
650 0 4 _aPsychoses, Substance-Induced
_xcomplications
700 1 _aKate, Natasha S
700 1 _aBhatankar, Swaroop S
700 1 _aKulkarni, Prathamesh S
773 0 _tIndian journal of pharmacology
_gvol. 47
_gno. 3
_gp. 328-9
856 4 0 _uhttps://doi.org/10.4103/0253-7613.157134
_zAvailable from publisher's website
999 _c24976964
_d24976964